Suppr超能文献

噻嗪类利尿剂和噻嗪样利尿剂:氢氯噻嗪、氯噻酮和吲达帕胺的综述。

Thiazide and the Thiazide-Like Diuretics: Review of Hydrochlorothiazide, Chlorthalidone, and Indapamide.

机构信息

Department of Pharmacy Practice and Science, College of Pharmacy, The University of Iowa, Iowa City, Iowa, USA.

Department of Family Medicine, Carver College of Medicine, The University of Iowa, Iowa City, Iowa, USA.

出版信息

Am J Hypertens. 2022 Jul 1;35(7):573-586. doi: 10.1093/ajh/hpac048.

Abstract

The term thiazide is universally understood to refer to diuretics that exert their principal action in the distal tubule. The thiazide class is heterogenous and can be further subdivided into compounds containing the benzothiadiazine ring structure-the thiazide-type (e.g., hydrochlorothiazide)-and those lacking the benzothiadiazine ring-the thiazide-like (e.g., chlorthalidone and indapamide) drugs. Thiazide-like agents are longer acting and constitute the diuretics used in most of the cardiovascular outcome trials that established benefits of treatment with diuretics, but pragmatic aspects, such as lack of availability in convenient formulations, limit their use. Regardless of class heterogeneity, thiazides have retained importance in the management of hypertension for over 60 years. They are reliably effective as monotherapy in a majority of hypertensive patients, and augment the efficacy of other classes of antihypertensives when used in combination. Importantly, a thiazide-based treatment regimen lowers cardiovascular events, and their sturdy effect reinforces their place among the recommended first-line agents to treat hypertension in major domestic and international hypertension guidelines. There are few head-to-head comparisons within the class, but potential differences have been explored indirectly as well as in non-blood pressure mechanisms and potential pleiotropic properties. Until proven otherwise, the importance of these differences remains speculative, and clinicians should assume that cardiovascular events will be lowered similarly across agents when equivalent blood pressure reduction occurs. Thiazides remain underutilized, with only about one-third of hypertensive patients receiving them. For many patients, however, a thiazide is an indispensable component of their regimen to achieve adequate blood pressure control.

摘要

噻嗪类药物通常被理解为作用于远曲小管的主要利尿剂。噻嗪类药物种类繁多,可进一步细分为含有苯并噻二嗪环结构的化合物(如氢氯噻嗪)和不含苯并噻二嗪环的化合物(如氯噻酮和吲达帕胺)。噻嗪样药物作用时间更长,是大多数心血管结局试验中使用的利尿剂,这些试验确立了利尿剂治疗的益处,但实际方面,如缺乏方便制剂的供应,限制了它们的使用。无论药物种类的异质性如何,噻嗪类药物在高血压治疗中已经有超过 60 年的重要地位。它们作为单一疗法在大多数高血压患者中具有可靠的疗效,并且在与其他类别的抗高血压药物联合使用时增强了它们的疗效。重要的是,基于噻嗪类药物的治疗方案可降低心血管事件的发生风险,其稳固的疗效强化了它们在主要国内外高血压指南中作为治疗高血压的一线推荐药物的地位。在该类药物中,很少有头对头的比较,但也间接探索了潜在的差异,包括非血压机制和潜在的多效性。在证明这些差异无效之前,这些差异的重要性仍然是推测性的,临床医生应假设在等效血压降低的情况下,不同药物的心血管事件降低情况相似。噻嗪类药物的使用率仍然较低,只有约三分之一的高血压患者使用它们。然而,对于许多患者来说,噻嗪类药物是实现充分血压控制的不可或缺的药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验